Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 7

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 7
---
 A Warrant Shares” and together with the Pre-Funded
Warrant Shares, the “Warrant Shares”) of Common Stock at an initial exercise price of $2.16 per share. The PIPE Shares, the
Series A Warrants, Series A Warrant Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares are collectively referred to as
the “Securities.”

The Pre-Funded Warrants are
exercisable (in cash or by cashless exercise) for shares of Common Stock for a nominal exercise price of $0.0001 per Pre-Funded Warrant
Share, are immediately exercisable upon issuance and expire when exercised in full.

The Series A Warrants are
exercisable following stockholder approval and expire two and one-half (2.5) years after the date of stockholder approval. If a registration
statement registering the resale of the shares of common stock underlying the Series A Warrants is not effective or available following
the date of stockholder approval, the holder may, in its sole discretion, elect to exercise the Series A Warrants through a cashless exercise.
The Series A Warrants also provide for alternative cashless exercise following stockholder approval (even if a registration statement
registering the issuance or resale of shares of common stock underlying the Series A Warrant is effective) where the holder of a Series
A Warrant has the right to receive an aggregate number of shares equal to the product of (x) the aggregate number of shares of common
stock that would be issuable upon a cash exercise of the Series A Warrant multiplied by (y) three (3.0). This alternative cashless exercise
amount is subject to proportional adjustments for stock splits, dividends, reclassifications and similar adjustments.

<div align='center'>1</div>

The exercise price of
the Series A Warrants will be reduced (but in no event increased) to the greater of (I) the floor price (as described below) and
(II) the lowest dollar-volume-weighted-average-price during the period beginning two full trading days prior to the Release Date and
ending on the 10th trading day after the Release Date (as described below). Upon any such resulting adjustment of the exercise price
in the Series A Warrants, the number of Series A Warrant Shares issuable under the Series A Warrants will be increased such that the
aggregate exercise price of a Series A Warrants (adjusted for any exercises by a holder prior to this adjustment)